Statins (HMG CoA-reductase inhibitors) are universally acknowledged as first-line treatment for medical prevention of atherosclerotic cardiovascular disease. Common cholesterol-lowering medicines known as statins may slightly increase the risk of developing diabetes, particularly at higher doses, according to a review of medical evidence by researchers Robert Beckett, Sarah Schepers and Sarah Gordon. However, the researchers concluded […]











